<DOC>
	<DOCNO>NCT01084993</DOCNO>
	<brief_summary>RATIONALE : Transradial coronary stenting associate less risk access site complication bleed compare femoral approach . Major bleed post-PCI strong independent predictor mortality MACE . Depending antithrombotic regimen access-site use , bleed relate access-site represent 50-80 % case . Whereas transradial approach minimize risk access-site bleeding , impact non-access site bleeding . Peri-procedural anemia also independent predictor mortality MACE . With femoral approach , bivalirudin compare heparin ± glycoproteins IIb-IIIa associated significant reduction access-site non-access site relate bleeding . In post-hoc analysis patient treat transradial approach ACUITY , trend non-access site bleeding ( organ bleed ) bivalirudin compare heparin ± glycoproteins IIb-IIIa . HYPOTHESES : In patient high-risk peri-procedural bleeding , bivalirudin ± glycoproteins IIb-IIIa reduces risk bleeding compare heparin ± glycoproteins IIb-IIIa . In patient high-risk bleed undergoing transradial PCI , bivalirudin significantly reduce incidence non-access site bleed peri-procedural anemia .</brief_summary>
	<brief_title>EArly Discharge After Transradial Stenting CoronarY Arteries High-Risk Patients Bleeding</brief_title>
	<detailed_description>OBJECTIVES : The primary objective compare incidence major bleed anemia 24h post-PCI patient high-risk bleed transradial PCI heparin bivalirudin .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>At least two follow additional criterion At least 70 yrs old Female gender Diabetes Creatinine clearance &lt; 60mL/min History gastrointestinal organ bleed Baseline anemia Current treatment glycoprotein IIbIIIa inhibitor Intolerance allergy ASA , clopidogrel ticlopidine preclude treatment 12 month Concurrent participation investigational study Femoral sheath ( artery )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Coronary artery stenting , transradial , intracoronary</keyword>
</DOC>